Overview of What You Will Learn
During the past two months, five manufacturers have implemented request or mandates which directly challenge Health and Human Services – Office of Pharmacy Affairs 2010 Contract Pharmacy Guidance. With the threat of additional manufacturers to follow suit, covered entities are grappling with how to respond to the influx of data requests and new distribution model restrictions. Patient privacy concerns, statutory requirements, and contractual obligation at top of mind for health system 340B leadership.
This webinar will address the recent actions taken by major pharmaceutical companies that target 340B drugs dispensed through contract pharmacies. These actions threaten to significantly impact the 340B benefit which help covered entities serve their patients. This content is designed for covered entities interested in learning more about the manufacturer actions and important related consideration.
What you will get from this webinar:
- Review manufacturer notice limiting 340B pricing for drugs when purchased through covered entity-contract pharmacy bill-to/ship-to arrangements.
- Discuss manufacturer letter to covered entities asking them to submit contract pharmacy claims data for the manufacturer’s products using a new online platform
- Highlight additional considerations including positions taken by other 340B stakeholders including covered entities, advocacy groups, third -party administrators and contract pharmacies
About the Speakers
Felicity Homsted PharmD, MBA, 340B ACE
Felicity Homsted serves as a Director of Research and Education with Turnkey Pharmacy Solutions specializing in 340B Program operations and compliance. From 2012 to 2018, Dr. Homsted was Chief Pharmacy for Penobscot Community Health Center Inc. (PCHC); Maine’s largest Federally Qualified Health Center serving over 70,000 patients across the state. She was responsible for the administration of four pharmacies, integrated pharmacy services and PCHC’s accredited community pharmacy and health systems pharmacy administration (HSPA) residency programs. She served as subject matter expert for the Apexus 340B Prime Vendor Program and faculty member for Apexus 340B University from 2014-2018.
Rich Bucher JD, RPh
Rich is a lead auditor, oversees client solutions, and manages legal and compliance-related issues. Rich is a pharmacist and attorney with over 25 years of experience in pharmacy leadership, healthcare law and compliance, and contracting. This includes practical experience with a large healthcare organization and large regional health plan dealing with operational and compliance/legal issues associated with managing a system-wide 340B program. Rich was also an adjunct professor of pharmacy and healthcare law at a pharmacy school in Utah for a number of years. He has conducted many external 340B audits for various covered entity types and supported many client 340B HRSA audits.